Nvigen

About:

NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications.

Website: http://nvigen.com

Twitter/X: Nvigen

Top Investors: TSVC, Qiuyuan Liu

Description:

NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Their pipeline of visionary solutions stems from our proprietary nanochemistry technology. NVIGEN was founded in the heart of Silicon Valley, from technologies that culminated from years of rigorous research at the University of California, Berkeley, and Stanford University. NVIGEN develops nanoparticle research reagents and devices for biomedical research applications. NVIGEN was incorporated in 2011.

Total Funding Amount:

$1.12M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)nvigen.com

Founders:

Aihua Fu, Guo Liang Yu

Number of Employees:

11-50

Last Funding Date:

2014-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai